Durch die Bündelung ihrer Kräfte werden Sartorius und Albumedix die Verfügbarkeit von wichtigen Komponenten für die Herstellung von neuartigen Therapien und Biopharmazeutika der nächsten Generation weltweit beschleunigen. Der Albumedix Campus in Nottingham, UK, wird als Bio-Innovations-…
Related Posts
U.S. Silica Announces Timing of Earnings Release and Investor Call
KATY, Texas, July 15, 2022 /PRNewswire/ — U.S. Silica Holdings, Inc. (NYSE: SLCA) announced today that it will release its…
Agricultural Lubricants Market to Surpass $4,333 Million Revenue by 2030, Says P&S Intelligence
NEW YORK, Sept. 15, 2022 /PRNewswire/ — According to the latest market research report published by P&S Intelligence, the size…
SKF AND QUAKER HOUGHTON ENTER COLLABORATION TO DELIVER CIRCULAR USE OF OIL
SKF and Quaker Houghton (NYSE: KWR), the global leader in industrial process fluids, have entered into a new collaboration to…
